These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13040333)

  • 21. Phenylindanedione; a deserving anticoagulant.
    HARPER BF; JOHNSON R
    J Med Assoc Ga; 1956 Apr; 45(4):149-50. PubMed ID: 13307153
    [No Abstract]   [Full Text] [Related]  

  • 22. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phenylindanedione anticoagulant therapy in obstetrics and gynecology].
    MALAGOLI F
    Ann Ostet Ginecol; 1955 Apr; 77(4):397-402. PubMed ID: 13259301
    [No Abstract]   [Full Text] [Related]  

  • 24. Experience with the new anticoagulant phenylindanedione in acute myocardial infarction; preliminary report of 50 cases.
    O'CONNOR WR; THOMPSON CE; BAKER LA
    Q Bull Northwest Univ Med Sch; 1952; 26(3):193-6. PubMed ID: 14957974
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anticoagulant and hemostatic therapy in obstetrics and gynecology. I. Phenylindanedione].
    STURA L; CRAVAREZZA F
    Quad Clin Ostet Ginecol; 1955 Jul; 10(7):409-26. PubMed ID: 13266979
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 27. OMEPHINE, A NEW ANTICOAGULANT.
    KOPTELOVA MN
    Fed Proc Transl Suppl; 1963; 22():1256-8. PubMed ID: 14079350
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 29. [Conditions of resistance to vitamin K antagonists].
    Marchal G; Samama M; Charon P
    Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood coagulation controls in ambulant use of anticoagulants].
    Gross R; Voss D
    Thromb Diath Haemorrh Suppl; 1964; 12():27-32. PubMed ID: 5882977
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione].
    Fontaine L; Grand M; Quentin Y; Merle S
    Med Pharmacol Exp Int J Exp Med; 1965; 13(3):137-54. PubMed ID: 4157600
    [No Abstract]   [Full Text] [Related]  

  • 32. Tolerance to phenindione of patients with different thromboembolic disorders.
    Nour-Eldin F; Lewis FJ
    Acta Haematol; 1964 Dec; 32(6):338-47. PubMed ID: 5005471
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biologic control of long-term anti-coagulating therapy with antivitamins K].
    Samama M; Casubolo L
    Angeiologie; 1967; 19(5):37-43. PubMed ID: 5621971
    [No Abstract]   [Full Text] [Related]  

  • 34. AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL.
    RICE-WRAY E
    Br Med J; 1964 Oct; 2(5413):837-43. PubMed ID: 14185634
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prophylaxis of vascular diseases].
    FLEISCHHACKER H
    Wien Med Wochenschr; 1953 Jul; 103(27):493-6. PubMed ID: 13090718
    [No Abstract]   [Full Text] [Related]  

  • 36. Safe per-operative anticoagulation.
    Wieberdink J
    Thorax; 1967 Nov; 22(6):567-71. PubMed ID: 6076513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
    Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
    J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of phenylindanedione on blood coagulation].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063
    [No Abstract]   [Full Text] [Related]  

  • 39. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION.
    MOSCHOS CB; WONG PC; SISE HS
    JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
    Pistorius MA; Said L; Planchon B
    J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.